Región Metropolitana de Santiago
Este organismo compró $35.329.096.472 en 11.633 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Sur Medical SpA.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $1367,1 M |
| 2025 | $2402,7 M |
| 2024 | $2107,2 M |
| 2023 | $2816,8 M |
| 2022 | $1338 M |
| 2021 | $1018,6 M |
| 2020 | $888,8 M |
| 2019 | $901,2 M |
| 2018 | $1471,2 M |
| 2017 | $786,1 M |
| 2016 | $14,2 mil M |
| 2015 | $919,8 M |
| 2014 | $428,8 M |
| 2013 | $340,8 M |
| 2012 | $359,5 M |
| 2011 | $701,4 M |
| 2010 | $913,7 M |
| 2009 | $590,7 M |
| 2008 | $571,8 M |
| 2007 | $1180,7 M |
| 2006 | $34,7 M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2980-65-AG26 | 30-01-2026 | Transportes, Logística y Distribución Group SpA | Recepcion Conforme | $3.423.475 |
| 2980-26-AG26 | 28-01-2026 | Farmacias Pedro Iturrieta Melendez EIRL | Recepcion Conforme | $2.399.833 |
| 2980-28-AG26 | 28-01-2026 | Comercializadora E-Comchile SpA | Recepcion Conforme | $216.878 |
| 2980-29-AG26 | 28-01-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $544.217 |
| 2980-30-AG26 | 28-01-2026 | Pfizer Chile S.A. | Recepcion Conforme | $139.591 |
| 2980-31-AG26 | 28-01-2026 | Pfizer Chile S.A. | Recepcion Conforme | $139.591 |
| 2980-32-AG26 | 28-01-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $410.514 |
| 2980-33-AG26 | 28-01-2026 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $3.094.000 |
| 2980-34-AG26 | 28-01-2026 | Distribuidora Qualimed Limitada | Recepcion Conforme | $356.929 |
| 2980-35-AG26 | 28-01-2026 | Emcure Pharma Chile SpA | Recepcion Conforme | $466.480 |
| 2980-36-AG26 | 28-01-2026 | Astrazeneca S.A. | Recepcion Conforme | $6.129.404 |
| 2980-37-AG26 | 28-01-2026 | Astrazeneca S.A. | Recepcion Conforme | $6.129.404 |
| 2980-38-AG26 | 28-01-2026 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $5.002.427 |
| 2980-39-AG26 | 28-01-2026 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $5.002.427 |
| 2980-40-AG26 | 28-01-2026 | Laboratorios Andromaco S.A. | Recepcion Conforme | $3.941.280 |
| 2980-41-AG26 | 28-01-2026 | Mamey Group SpA | Recepcion Conforme | $485.520 |
| 2980-42-AG26 | 28-01-2026 | Clinical Market S.A. | Recepcion Conforme | $1.872.156 |
| 2980-43-AG26 | 28-01-2026 | Distribuidora Qualimed Limitada | Recepcion Conforme | $1.414.910 |
| 2980-44-AG26 | 28-01-2026 | Inversiones Sb S.A. | Recepcion Conforme | $2.783.410 |
| 2980-45-AG26 | 28-01-2026 | Astrazeneca S.A. | Recepcion Conforme | $3.795.524 |
| 2980-46-AG26 | 28-01-2026 | Astrazeneca S.A. | Recepcion Conforme | $4.955.084 |
| 2980-47-AG26 | 28-01-2026 | Astrazeneca S.A. | Recepcion Conforme | $5.678.261 |
| 2980-48-AG26 | 28-01-2026 | Pfizer Chile S.A. | Recepcion Conforme | $3.519.235 |
| 2980-49-AG26 | 28-01-2026 | Novofarma Service S.A. | Recepcion Conforme | $3.570.071 |
| 2980-50-AG26 | 28-01-2026 | Astrazeneca S.A. | Recepcion Conforme | $4.955.084 |
| 2980-51-AG26 | 28-01-2026 | Novartis Chile S.A. | Recepcion Conforme | $2.942.880 |
| 2980-52-AG26 | 28-01-2026 | Novartis Chile S.A. | Recepcion Conforme | $5.895.474 |
| 2980-53-AG26 | 28-01-2026 | Drogueria B y F SpA | Recepcion Conforme | $6.164.200 |
| 2980-54-AG26 | 28-01-2026 | Novartis Chile S.A. | Recepcion Conforme | $5.395.291 |
| 2980-55-AG26 | 28-01-2026 | Novartis Chile S.A. | Recepcion Conforme | $5.539.500 |
